Entering text into the input field will update the search result below

Myovant stock pops as Sumitovant to acquire remaining stake for $1.7B

Oct. 24, 2022 6:37 AM ETMyovant Sciences Ltd. (MYOV), DNPUFBy: Ravikash, SA News Editor10 Comments

Female patient speaking with her paediatrician in a doctors office


Japan's Sumitovant Biopharma is acquiring the remaining 48% stake in Myovant Sciences (NYSE:MYOV) for $1.7B, which it currently does not own to take the London-based women's health company private.

Sumitovant, a unit of Sumitomo Pharma (OTCPK:DNPUF), will acquire all outstanding

Recommended For You

Comments (10)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

LRNMO25 profile picture
Take your profits if you haven't.
Worth more although can't look a 2X in the mouth in 22.
BadgerMike profile picture
Was looking for a price above $30. But a win is a win.
Cool, another one nailed!
@PITX3 where to next? Another bio?
@The Reasonable Man I was doubting to add to $AUPH they have a good asset but failed management execution, that asset in the hands of a major would be a blockbuster for sure
theredbaron8888 profile picture
@PITX3 , agreed. Awful execution at $AUPH.

Given up on $CLLS, @PITX3 ?
LRNMO25 profile picture
Not unexpected.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.